Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-684-7
CAS number: 80793-17-5
In vitro gene mutation test in bacteria
The mutagenic activity of AC-6000 was examined in the reverse mutation
test by using bacterial strains Salmonella typhimurium TA100, TA1535,
TA98 and 1537 and Escherichia coli WP2uvrA (Hita Laboratory, 2006). The
GLP-compliant study was performed comparable to OECD guideline 471. The
reverse mutation test was composed of a dose range finding and a main
test. The pre-incubation method was used for all bacterial strains in
both the presence and the absence of metabolic activation using the
following concentrations: 4.88, 19.5, 78.1, 313, 1250 and 5000 µg/plate
(dose range finding test) and 313, 625, 1250, 2500 and 5000 µg/plate
(main test). In both the dose range finding test and the main test, the
number of revertant colonies in the substance treatment groups in all
test strains with and without S-9 mix was less than twice that in the
solvent control. Bacterial growth inhibition and precipitation of the
substance were not observed at any doses in the groups of treatment in
all test strains with and without S-9 mix. Therefore it is concluded
that the mutagenic activity of AC-6000 is considered negative under the
test conditions employed.
In vitro chromosome aberration test with mammalian cells
The ability of AC-6000 to induce chromosomal aberrations was
investigated by using Chinese hamster lung fibroblasts (CHL/IU cells) in
a study comparable to OECD guideline 473 (Hita Laboratory, 2007). Based
on the results of cell growth inhibition test, the concentrations of the
test substance in the chromosomal aberration test were set at 870, 1740
and 3480 µg/mL in short-term treatments (6 hours) without and with S-9
mix and in a 24 hours continuous treatment. In the observation, the
frequencies of cells with structural aberrations and numerical
aberrations were scored.
Cytotoxicity was not observed. Precipitation of the test substance was
observed at all concentrations. The frequencies of cells with structural
and numerical aberrations were below 5% at all tested concentrations of
the test substance in all treatment methods. It was concluded that
AC-6000 did not induce chromosomal aberrations under the present test
Short description of key information:
The substance was negative both in an Ames test and in an in vitro
chromosomal aberration test.
Endpoint Conclusion: No adverse effect observed (negative)
Based on the results of the in vitro tests, the substance does not need to be classified according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Ce site web utilise des cookies afin de vous garantir la meilleure expérience possible sur nos sites web.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again